See every side of every news story
Published loading...Updated

PBS listing for drug to fight rare disorder that can attack optic nerves

Summary by Insight
A drug to fight a rare disorder that can impact on vision has been listed on the PBS. Image: benjaminnolte/stock.adobe.com.Alexion, AstraZeneca rare disease treatment Ultomiris (ravulizumab rch) has become the first targeted treatment option to be reimbursed for people living with Neuromyelitis Optica Spectrum Disorder (NMOSD), which can attack optic nerves and result in vision loss. A media release said the treatment was listed on the Pharmaceu…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Insight broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.